Liver Diseases  >>  ALS-2158  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALS-2158 / J&J, Vertex
NCT01554085: First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Terminated
1
78
RoW
ALS-002158, Placebo
Alios Biopharma Inc., Vertex Pharmaceuticals Incorporated
Hepatitis C, Chronic
09/12
09/12

Download Options